Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 85
Oncology Drugs 85
Optical 76
Optical Disorders Drugs 75
Immune Disorders Drugs 72
Cardiovascular Drugs 51
Musculoskeletal Disorders Drugs 40
Dermatological Drugs 38
Biopharmaceuticals 36
Biotechnology 31
Genomics 29
Clinical Trials 29
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 23
Skin Cancer Drugs 21
Central Nervous System Drugs 19
Infectious Diseases Drugs 17
Respiratory Drugs 17
Allergy and Immunology 16
Infusions and Injectables 14
Gastrointestinal Drugs 14
Allergy Drugs 14
Drugs by Therapeutic Area 13
Lung Cancer Drugs 11
Dermatology 10
Hematological Drugs 10
Oncology 10
Leukemia Drugs 9
Needles and Syringes 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Diagnostics 7
Biosimilars and Biosuperiors 7
Enzymes 6
Vaccines 6
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Ovarian Cancer Drugs 5
Transdermal and Transmucosal Drug Delivery 5
Liver and Kidney Disorders Drugs 5
Company Reports 4
Therapeutic Area 4
Pulmonary Medicine 4
Cardiovascular Devices 4
Drug Delivery 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Proteomics 3
Laboratory Equipment 3
Pediatrics 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Pharmacoeconomics 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Cardiology 2
Endocrinology 2
Neurology 1
Hepatology 1
Generic Drugs 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

703 Results (Page 15 of 36)
- Relevance
  Sort by

Sinusitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
111 Pages
Global

From

€1757EUR$2,000USD£1,516GBP

Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
245 Pages
Global

From

€1757EUR$2,000USD£1,516GBP

Grass Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
48 Pages
Global

From

€1757EUR$2,000USD£1,516GBP

Cat Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
28 Pages
Global

From

€1757EUR$2,000USD£1,516GBP

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
820 Pages
Global

From

€1757EUR$2,000USD£1,516GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Leukemia Therapeutics - Global Strategic Business Report

 Report
July 2025
193 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Cervical Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€2197EUR$2,500USD£1,895GBP

Uveal Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
207 Pages
Global

From

€1757EUR$2,000USD£1,516GBP

Red Biotechnology Market Report and Forecast 2024-2032

 Report
November 2023
172 Pages
Global

From

€3162EUR$3,599USD£2,728GBP

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
527 Pages
Global

From

€2197EUR$2,500USD£1,895GBP

Cancer Biomarkers Market: Industry Trends and Global Forecasts 2024-2035: Distribution by Type of Biomarker, Type of Cancer and Key Geographical Regions

 Report
April 2024
309 Pages
Global

From

€3953EUR$4,499USD£3,410GBP

Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2023-2033

 Report
October 2023
284 Pages
Global

From

€4739EUR$5,583USD£3,950GBP

Collaboration Deals in Pharmaceuticals 2019-2025

 Report
April 2025
950 Pages
Global

From

€3510EUR$3,995USD£3,028GBP

B-Cell Chronic Lymphocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
139 Pages
Global

From

€1757EUR$2,000USD£1,516GBP

Dermatological Drugs Market Report 2024-2034

 Report
February 2024
280 Pages
Global

From

€5219EUR$6,148USD£4,350GBP

Basal Cell Carcinoma Treatment Market by Treatment Type, Drug Class, End User, Route Of Administration, Distribution Channel, Patient Age Group, Stage - Global Forecast to 2030

 Report
May 2025
182 Pages
Global

From

€3115EUR$3,545USD£2,687GBP

€3461EUR$3,939USD£2,986GBP

Next Generation Drug Conjugates Market: Distribution by Type of Targeting Ligand, Type of Payload, Type of Therapy, Route of Administration, Target Disease Indication and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

 Report
September 2023
120 Pages
Global

From

€4217EUR$4,799USD£3,637GBP

Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report

 Report
July 2025
122 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

 Report
January 2023
90 Pages
Global

From

€3071EUR$3,495USD£2,649GBP

Targeted Oncology Therapeutics: Lung Cancers

 Report
October 2021
82 Pages
Global

From

€3383EUR$3,850USD£2,918GBP

703 Results (Page 15 of 36)
- 1
- 13
- 14
- 15
- 16
- 17

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.